Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Aethlon Medical (AEMD) over the last 15 years, with Q1 2025 value amounting to -$1.7 million.

  • Aethlon Medical's Free Cash Flow rose 3501.05% to -$1.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$7.6 million, marking a year-over-year increase of 2634.84%. This contributed to the annual value of -$7.6 million for FY2025, which is 2634.84% up from last year.
  • Latest data reveals that Aethlon Medical reported Free Cash Flow of -$1.7 million as of Q1 2025, which was up 3501.05% from -$2.0 million recorded in Q4 2024.
  • Aethlon Medical's 5-year Free Cash Flow high stood at -$1.7 million for Q1 2025, and its period low was -$3.6 million during Q3 2022.
  • Its 5-year average for Free Cash Flow is -$2.5 million, with a median of -$2.4 million in 2023.
  • Its Free Cash Flow has fluctuated over the past 5 years, first crashed by 8854.94% in 2022, then surged by 3558.11% in 2024.
  • Aethlon Medical's Free Cash Flow (Quarter) stood at -$2.8 million in 2021, then rose by 24.26% to -$2.1 million in 2022, then decreased by 13.51% to -$2.4 million in 2023, then grew by 15.66% to -$2.0 million in 2024, then increased by 17.02% to -$1.7 million in 2025.
  • Its Free Cash Flow stands at -$1.7 million for Q1 2025, versus -$2.0 million for Q4 2024 and -$2.2 million for Q3 2024.